Third Eye Retroscope Randomized Clinical Evaluation
Launched by AVANTIS MEDICAL SYSTEMS · Jan 6, 2010
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
Colonoscopy is generally agreed to be the best method for detecting and removing pre-cancerous polyps, but some lesions can be missed, especially if they are located behind folds in the lining of the colon or behind flexures (sharp bends) in the colon.
The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon. Previous studies have shown the device to be effective for detecting additional polyps that could not have been...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;
- • The patient must understand and provide written consent for the procedure.
- Exclusion Criteria:
- • Patients with a history of colonic resection;
- • Patients with inflammatory bowel disease;
- • Patients with a personal history of polyposis syndrome;
- • Patients with suspected chronic stricture potentially precluding complete colonoscopy;
- • Patients with diverticulitis or toxic megacolon;
- • Patients with a history of radiation therapy to abdomen or pelvis;
- • Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.
About Avantis Medical Systems
Avantis Medical Systems is a pioneering clinical trial sponsor dedicated to advancing the field of medical technology through innovative solutions for gastrointestinal procedures. With a strong focus on developing cutting-edge endoscopic devices, the company aims to enhance patient outcomes and streamline clinical workflows. Leveraging a robust research framework and a commitment to quality, Avantis collaborates with healthcare professionals to conduct rigorous clinical trials that assess the safety and efficacy of its products. Through these efforts, the company strives to address unmet medical needs and contribute to the evolution of minimally invasive treatments in gastroenterology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lebanon, New Hampshire, United States
Dallas, Texas, United States
Utrecht, , Netherlands
Baltimore, Maryland, United States
Kansas City, Missouri, United States
Providence, Rhode Island, United States
Brussels, , Belgium
Milan, , Italy
London, , United Kingdom
Patients applied
Trial Officials
Peter D. Siersema, MD, PhD
Principal Investigator
UMC Utrecht
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials